abstract |
Inhibition of the activity of members of the MAPEG family is desirable and / or required in the manufacture of a medicament for the treatment of a disease, particularly for the treatment of inflammation. There is provided use of a compound of the formula (wherein Y, W 1 to W 4 , Z 1 to Z 4 and R have the meanings described herein), or a pharmaceutically acceptable salt thereof. |